In MM, several interleukins, such as IL-6, IL-3, IL-17, IL-1, and IL-11, regulate cell proliferation, survival, and drug resistance, and promote osteolytic lesions, thus underscoring the pathogenetic role of the deregulated immune system in MM. This evidence concerns the gene IL11 and Miyoshi myopathy.